Kishchuk Vasyl V., Bondarchuk Oleksandr D, Kostyuchenko Andriy V., Tytarenko Nataliya V., Dmitrenko Ihor V, Bartsihovskyiy Andriy I, Lobko Kateryna A
Pirogov Regional Clinical Hospital, Vinnytsia, Ukraine
Wiad Lek. 2019 Oct 31;72(10):1904-1908.
Scleroma is a rare chronic granulomatous disease of the upper respiratory tract caused by Klebsiella pneumoniae subsp. rhinoscleromatis. To date its pathogenesis is as yet little understood. At the same time, scleroma is associated with a number of immune system disturbances. The aim: To study local immunity status of oropharynx in patients with scleroma, and to compare its parameters in various clinical forms of the disease.
20 apparently healthy subjects and 92 patients with scleroma (33 males, 59 females) underwent clinical immunologic evaluation. There were 31 patients with dominating infiltrative form of scleroma, 30 – with dominating atrophic form, 31 – with dominating scarring form. Concentration of secretory and monomeric immunoglobulin A, immunoglobulin G, α-interferon, interleukin 1β in oropharyngeal secretion was determined by enzyme immunoassay.
Patients with scleroma were found to have altered local immunity of oropharyngeal secretion. There was a strong tendency for decreased concentration of secretory immunoglobulin A - 1.3-2.0 times, and decreased immunoglobulin G level – 1.5-2.3 times (р < 0.05) as compared to the values in healthy subjects. Specific features of local immunity in oropharyngeal secretion in various forms of scleromatous inflammatory process in upper respiratory tract were found: the most significant decrease of α-interferon concentration in atrophic and scarring forms of the disease, and the largest increase of anti-inflammatory interleukin 1β and immune complex concentration in infiltrative form of scleroma.
The study revealed deficiency of local immunity factors in oropharynx, being indicative of immunopathogenetic role of diagnosed disturbances in development and persistence of chronic inflammation in scleroma, and emphasizing the necessity of immunocorrection in complex therapy of the disease.
硬结病是由鼻硬结克雷伯菌引起的上呼吸道罕见慢性肉芽肿性疾病。迄今为止,其发病机制仍知之甚少。同时,硬结病与多种免疫系统紊乱有关。目的:研究硬结病患者口咽部局部免疫状态,并比较该疾病不同临床类型的相关参数。
对20名健康受试者和92例硬结病患者(33例男性,59例女性)进行临床免疫学评估。其中31例患者以浸润型硬结病为主,30例以萎缩型为主,31例以瘢痕型为主。采用酶免疫分析法测定口咽分泌物中分泌型和单体免疫球蛋白A、免疫球蛋白G、α干扰素、白细胞介素1β的浓度。
发现硬结病患者口咽分泌物局部免疫发生改变。与健康受试者相比,分泌型免疫球蛋白A浓度有显著降低趋势,降低了1.3 - 2.0倍,免疫球蛋白G水平降低了1.5 - 2.3倍(р < 0.05)。在上呼吸道硬结性炎症过程的不同形式中,口咽分泌物局部免疫具有特定特征:在萎缩型和瘢痕型疾病中,α干扰素浓度下降最为显著,而在浸润型硬结病中,抗炎性白细胞介素1β和免疫复合物浓度增加最为明显。
该研究揭示了口咽部局部免疫因子的缺乏,表明所诊断的紊乱在硬结病慢性炎症的发生和持续发展中具有免疫致病作用,并强调了在该疾病综合治疗中进行免疫纠正的必要性。